Shin-Ichiro Fujii

12PUBLICATIONS
19CO-AUTHORS
Tumour immunologyMedical molecular engineering of nucleic acids and proteinsCancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 03, 2026
Multiomics Dissection Reveals Natural Killer Cell-CD8+ T-cell Cooperation in Shaping an Immunostimulatory Tumor Microenvironment.

|Mar 30, 2026
Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.

Masahiro Okada, Satoru Yamasaki, Go R Sato

|Oct 30, 2024
Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer.

Yuhya Hirahara, Kanako Shimizu, Satoru Yamasaki

|Sep 04, 2024
ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy.

Masahiro Okada, Satoru Yamasaki, Hiroshi Nakazato

|Oct 31, 2023
Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells.

Tomonori Iyoda, Kanako Shimizu, Takaho Endo

|Jul 03, 2023
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor.

Kanako Shimizu, Shogo Ueda, Masami Kawamura

Pageof 2

Frequent Collaborators

2 joint publications

Satoru Yamasaki

2 joint publications

Hiroshi Nakazato

2 joint publications

Takuya Ishibashi

2 joint publications

Kanako Shimizu